$2.82
0.082.92%
At close: -
$2.90
0.082.84%
After Hours: Apr 11, 7:49 PM EDT
Comments
Loading...
Puma Biotechnology Earnings Estimates, EPS & Revenue | NASDAQ:PBYI | Benzinga
Puma Biotechnology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$0.060
Quarterly Revenue Estimate
$47.50M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$230.47M
Analyze the earnings history of Puma Biotechnology using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PBYI | Puma Biotechnology | -$0.05 | $0.06 | — | — | $43.80M | $47.50M | — | — | 05/01/2025 | Get Alert |
| PBYI | Puma Biotechnology | $0.31 | $0.14 | $0.43 | 207.14% | $72.20M | $52.50M | $59.10M | 12.57% | 02/27/2025 | Get Alert |
| PBYI | Puma Biotechnology | $0.17 | $0.35 | $0.45 | 28.57% | $56.10M | $70.65M | $80.50M | 13.94% | 11/07/2024 | Get Alert |
| PBYI | Puma Biotechnology | $0.10 | -$0.10 | -$0.05 | 50.00% | $54.60M | $47.30M | $47.10M | -0.42% | 08/01/2024 | Get Alert |
| PBYI | Puma Biotechnology | $0.09 | -$0.22 | -$0.05 | 77.27% | $52.80M | $41.05M | $43.80M | 6.70% | 05/02/2024 | Get Alert |
| PBYI | Puma Biotechnology | -$0.07 | $0.30 | $0.31 | 3.33% | $65.70M | $73.55M | $72.20M | -1.84% | 02/29/2024 | Get Alert |
| PBYI | Puma Biotechnology | $0.05 | $0.08 | $0.17 | — | $57.10M | $57.95M | $56.10M | -3.19% | 11/02/2023 | Get Alert |
| PBYI | Puma Biotechnology | $0.28 | $0.07 | $0.10 | 42.86% | $59.50M | $51.37M | $54.60M | 6.29% | 08/03/2023 | Get Alert |
| PBYI | Puma Biotechnology | -$0.01 | -$0.07 | $0.09 | 228.57% | $45.70M | $49.63M | $52.80M | 6.39% | 05/04/2023 | Get Alert |
| PBYI | Puma Biotechnology | $0.21 | $0.01 | -$0.07 | -800.00% | $55.40M | $57.06M | $65.70M | 15.14% | 03/02/2023 | Get Alert |
| PBYI | Puma Biotechnology | -$0.99 | -$0.05 | $0.05 | 200.00% | $46.20M | $50.13M | $57.10M | 13.90% | 11/03/2022 | Get Alert |
| PBYI | Puma Biotechnology | $0.32 | — | $0.28 | — | $53.40M | $51.97M | $59.50M | 14.49% | 08/04/2022 | Get Alert |
| PBYI | Puma Biotechnology | $0.55 | -$0.17 | -$0.01 | 94.12% | $98.20M | $45.07M | $45.70M | 1.40% | 05/05/2022 | Get Alert |
| PBYI | Puma Biotechnology | -$0.14 | — | $0.21 | — | $52.60M | $47.17M | $55.40M | 17.45% | 03/03/2022 | Get Alert |
| PBYI | Puma Biotechnology | -$0.60 | -$0.31 | -$0.99 | -219.35% | $50.80M | $53.31M | $46.20M | -13.34% | 11/04/2021 | Get Alert |
| PBYI | Puma Biotechnology | $0.35 | -$0.34 | -$0.13 | 61.76% | $70.60M | $51.60M | $53.40M | 3.49% | 08/05/2021 | Get Alert |
| PBYI | Puma Biotechnology | -$0.43 | $0.09 | $0.55 | 511.11% | $51.20M | $71.47M | $98.20M | 37.40% | 05/06/2021 | Get Alert |
| PBYI | Puma Biotechnology | -$0.29 | -$0.29 | -$0.14 | 51.72% | $62.90M | $52.79M | $52.60M | -0.36% | 02/25/2021 | Get Alert |
| PBYI | Puma Biotechnology | -$0.44 | -$0.39 | -$0.60 | -53.85% | $56.40M | $53.05M | $50.80M | -4.24% | 11/05/2020 | Get Alert |
| PBYI | Puma Biotechnology | -$0.97 | -$0.30 | $0.35 | 216.67% | $53.90M | $58.21M | $70.60M | 21.29% | 08/06/2020 | Get Alert |
| PBYI | Puma Biotechnology | -$0.26 | -$0.73 | -$0.43 | 41.10% | $99.10M | $47.06M | $51.20M | 8.80% | 05/07/2020 | Get Alert |
Puma Biotechnology (PBYI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $0.43 | $0.14 | 207.1 % |
| Q3 | 2024-11-07 | $0.45 | $0.35 | 28.6 % |
| Q2 | 2024-08-01 | $-0.05 | $-0.10 | 50.0 % |
| Q1 | 2024-05-02 | $-0.05 | $-0.22 | 77.3 % |
Puma Biotechnology (PBYI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $59.10M | $52.50M | 12.6 % |
| Q3 | 2024-11-07 | $80.50M | $70.65M | 13.9 % |
| Q2 | 2024-08-01 | $47.10M | $47.30M | -0.42 % |
| Q1 | 2024-05-02 | $43.80M | $41.05M | 6.70 % |
FAQ
When is Puma Biotechnology (NASDAQ:PBYI) reporting earnings?
Puma Biotechnology (PBYI) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Puma Biotechnology (NASDAQ:PBYI)?
The Actual EPS was $0.43, which beat the estimate of $0.14.
What were Puma Biotechnology’s (NASDAQ:PBYI) revenues?
The Actual Revenue was $59.1M, which beat the estimate of $52.5M.
Browse earnings estimates, EPS, and revenue on all stocks.